KL
Kevin Lee sold $27K of BCYC stock
Kevin Lee, Chief Executive Officer of Bicycle Therapeutics Plc (BCYC), sold 7,805 shares of BCYC stock worth $27K, per an SEC Form 4 filed Oct 6, 2026.
It was an open-market sale.
The trade happened on Oct 2, 2026, 4 days before it was made public.
BCYC has moved -14.2% since the trade date, from $3.38 to $2.90 (Nov 20, 2026 close).
- Traded
- Oct 2, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 4 days
- Price since
- -14.2%
- Role
- Chief Executive Officer
- Source
- SEC Form 4